rs2681472 — ATP2B1

ATP2B1 — The Calcium Pump Variant Underlying Common Hypertension

Your blood vessels are in constant tension between vasoconstriction and relaxation, a balance governed in part by calcium. The ATP2B1 gene¹¹ ATP2B1 gene
encodes Plasma Membrane Ca²⁺-ATPase 1 (PMCA1), the primary pump that ejects calcium ions from inside cells to the extracellular space. In vascular smooth muscle and cardiac endothelial cells, PMCA1 is essential for keeping intracellular calcium low enough to prevent chronic vasoconstriction. The rs2681472 variant near ATP2B1 is one of the most robustly replicated blood pressure loci in human genetics, achieving genome-wide significance in multiple large consortia and replicated across populations spanning Europe, East Asia, Africa, South Asia, and the Middle East.

The Mechanism

rs2681472 sits within an intron of ATP2B1 on chromosome 12q21.33²² chromosome 12q21.33
GRCh38 position 89,615,182. Although it does not alter the protein sequence, it functions as an expression quantitative trait locus (eQTL)³³ expression quantitative trait locus (eQTL)
A genetic variant that influences how much a nearby gene is expressed, often by affecting regulatory elements in the DNA in artery and aorta tissue. The A allele is associated with reduced ATP2B1 expression in these vascular tissues, meaning fewer functioning PMCA1 pumps per cell.

When PMCA1 activity is reduced, intracellular calcium accumulates in vascular smooth muscle cells. Elevated intracellular Ca²⁺ sustains smooth muscle contraction, narrowing arterial lumen diameter and raising vascular resistance. In parallel, PMCA1 interacts directly with eNOS⁴⁴ eNOS
endothelial nitric oxide synthase, the enzyme producing the vasodilator nitric oxide: reduced PMCA1 expression impairs eNOS activity and lowers nitric oxide production, removing a key vasodilatory brake. Mouse models confirm this — heterozygous PMCA1-null mice show impaired NO production and elevated blood pressure, and vascular smooth muscle-specific ATP2B1 knockout mice exhibit hypertension with increased intracellular calcium.

Structural changes may begin years before clinical hypertension. In aging heterozygous PMCA1 null mice, small mesenteric artery walls thickened and lumens narrowed before blood pressure rose, suggesting the A allele may drive subclinical vascular remodelling⁵⁵ subclinical vascular remodelling
structural changes in artery walls that increase stiffness and resistance before measurable blood pressure elevation occurs.

The Evidence

The original discovery came from the CHARGE and Global BPgen Consortia⁶⁶ CHARGE and Global BPgen Consortia
Cohorts for Heart and Aging Research in Genome Epidemiology, and the Global Blood Pressure Genetics Consortium — two large European-ancestry GWAS collaborations: in a joint analysis of 63,569 participants, rs2681472 reached genome-wide significance for systolic BP (p=3.5×10⁻¹¹), diastolic BP (p=3.7×10⁻⁸), and hypertension (p=1.7×10⁻⁸). The odds ratio for hypertension was 1.17 per A allele, with additive effects — AA homozygotes carrying approximately 37% higher odds than GG homozygotes.

A 2021 meta-analysis of 91,997 individuals⁷⁷ 2021 meta-analysis of 91,997 individuals confirmed the association with quantitative blood pressure traits: each A allele adds ~0.92 mmHg to systolic BP and ~0.50 mmHg to diastolic BP. In European ancestry populations the hypertension OR is 1.16 (95%CI 1.13–1.20); in East Asians, 1.14 (1.10–1.17). Replication studies span Korea, China, Saudi Arabia, Iran, Burkina Faso, and Russia.

An important dietary interaction has been documented: ATP2B1 major-allele carriers (AA and AG) show substantially greater hypertension risk when calcium intake is low and the dietary sodium-to-potassium ratio is high, suggesting PMCA1 insufficiency is exacerbated by dietary calcium deficit. Note: this diet-gene interaction evidence derives from a Korean study of the related variant rs17249754 (in partial LD with rs2681472), not directly from rs2681472 itself; the directional effect is expected to apply given the shared locus, but direct replication for rs2681472 is not yet published. Salt sensitivity studies in Korean populations⁸⁸ Salt sensitivity studies in Korean populations found rs2681472 to be among the strongest genetic predictors of salt-sensitive blood pressure response.

Evolutionary analyses show rs2681472 has undergone positive selection, with significant population differentiation between African and Asian populations (FST=0.20). The ancestral African-dominant allele may have provided adaptive vasoconstriction advantages in hot climates that become maladaptive as a hypertension risk in modern environments.

Practical Actions

For AA and AG carriers, two genotype-specific strategies have the strongest evidence base. First, maintaining adequate dietary calcium (and supplementing if dietary intake is low) directly addresses the gene-environment interaction: the blood pressure risk from this variant is substantially amplified at low calcium intakes. Second, limiting dietary sodium while maintaining high potassium intake targets the salt-sensitivity dimension — AA carriers show the greatest BP reduction from sodium restriction. Monitoring resting blood pressure at home (rather than relying on annual clinical checks) enables early detection of the gradual BP elevation this variant causes.

GG carriers have meaningfully lower blood pressure risk at this locus and show less BP sensitivity to dietary sodium.

Interactions

rs2681472 functions alongside other blood pressure GWAS variants in the same vascular calcium signaling pathway. The closely studied rs17249754 (also at the ATP2B1 locus, ~80 kb downstream) is in partial linkage disequilibrium with rs2681472 and shows stronger association in East Asian populations. Carriers of risk alleles at both loci have compounded BP elevation and stronger dietary calcium-hypertension interaction.

Within the renin-angiotensin-aldosterone system, ATP2B1 variants interact functionally with AGT (rs699, angiotensinogen M235T) — angiotensin II signaling through the AT1 receptor raises intracellular calcium in vascular smooth muscle, a signal that PMCA1 must clear. Reduced PMCA1 capacity in A allele carriers means that angiotensin II-driven calcium signals persist longer, amplifying vasoconstriction. Carriers of both the AGT T235 risk allele and the ATP2B1 A risk allele likely have compounded calcium-mediated BP elevation, though formal compound interaction studies are needed.